Serum Glutamine Synthetase Has No Value as a Diagnostic Biomarker for Alzheimer's Disease

Author： Vermeiren Yannick  

Publisher： Springer Publishing Company

ISSN： 0364-3190

Source： Neurochemical Research, Vol.36, Iss.10, 2011-10, pp. : 1858-1862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer's Disease

By Oh Esther  

NeuroMolecular Medicine, Vol. 10, Iss. 3, 2008-09 ,pp. : 195-207

Humana Press, Inc

Access to resources Recommend Favorite

CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 4, 2014-05 ,pp. : 340-348

Bentham Science Publishers

Access to resources Recommend Favorite

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 10, 2016-08 ,pp. : 1173-1177

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 12, Iss. 9, 2015-11 ,pp. : 829-836

Bentham Science Publishers

Access to resources Recommend Favorite

A Possible New Diagnostic Biomarker in Early Diagnosis of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 6, Iss. 6, 2009-12 ,pp. : 519-524

Bentham Science Publishers

Access to resources Recommend Favorite